Compare ImmunityBio Inc. Common Stock (IBRX) vs Seagate Technology Holdings PLC (STX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Seagate Technology Holdings PLC — how do they compare? ImmunityBio Inc. Common Stock trades at $10.72 (market cap $10.51B), while Seagate Technology Holdings PLC trades at $788.71 (market cap $176.19B). The key difference: Seagate Technology Holdings PLC is far larger — about 16.8× ImmunityBio Inc. Common Stock's market cap, and Seagate Technology Holdings PLC pays a 0.38% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 1 Days and Seagate Technology Holdings PLC for 41 Days on average.
| IBRX | STX | |
|---|---|---|
Market Cap | $10.51B | $176.19B |
Volume | 10,445,785 | 5,061,875 |
Sector | Health | Technology |
52-Week High | $11.55 | $1.09K |
52-Week Low | $1.98 | $211.63 |
Typical Hold Time | 1 Days | 41 Days |
Enterprise Value | $10.97B | $178.34B |
Dividend Yield | — | 0.38% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Seagate Technology (STX) trades at $780.39, down 3.34% amid concerns about increased competition from Toshiba's planned HDD production expansion. The stock shows strong fundamental performance with Q2 2026 EPS beating expectations at $5.71 versus $5.10, and maintains robust profitability with 26.11% net margin and 371.53% ROE. Technical indicators signal bearish momentum with price below key pivot points, though RSI suggests potential oversold conditions at 24.89.
Despite near-term competitive pressures, Seagate's dominant position in AI storage and strong earnings trajectory support long-term growth. The consensus price target of $1,130 represents 45% upside potential, but investors face risks from pricing pressure and market share erosion as Toshiba expands capacity in 2027.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Seagate Technology Holdings PLC
Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital
Read more on STX →
